[Field study on the therapeutic value of trasylol in traumatic shock].
A report of the results of a multicenter study including 4686 patients concerning the therapeutic value of Trasylol (Aprotinin) in traumatic shock. The group treated additionally with Trasylol showed, beside a reduced overall mortality, a statistically significant reduction of mortality in those treated within the first 30 min after the injury. Surgery performed in the posttraumatic stage showed a lower mortality in the Trasylol group. The importance of a time factor in shock treatment and the effects of Trasylol in traumatic shock are emphasized.
D007611:Aprotinin / Q000008:administration & dosage / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D011379:Prognosis; D012774:Shock, Traumatic / Q000188:drug therapy*; D013997:Time Factors
D007611:Aprotinin
Feldstudie über den therapeutischen Wert von Trasylol beim traumatischen Schock